Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

3:55 PM - 4:00 PM ET

Closing
Speaker: Solanki, Abhishek, MD, MS - Loyola University Medical Center, Maywood, IL - Illinois
3:55 PM - 4:00 PM ET

Closing
Speaker: Rana, Suresh, PhD - Lynn Cancer Institute, Boca Raton, FL
5:00 PM - 5:10 PM ET

226 - REDEL Trial: Phase II Trial of Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Speaker: Kharofa, Jordan, MD - University of Cincinnati, Cincinnati, OH
5:00 PM - 5:10 PM ET

231 - AI-Based Brachytherapy Auto-Planning for Cervical Cancer in Low- and Middle-Income Countries
Speaker: Sun, Baozhou, PhD, MBA - Washington University, St. Louis, St. Louis, MO
5:00 PM - 5:05 PM ET

Introduction
Speaker: Miccio, Joseph, MD - Penn State Hershey Medical Center, Hershey, PA
5:00 PM - 5:05 PM ET

Introduction
Speaker: Gao, Hao, PhD - UT Southwestern Medical Center, Dallas, TX
5:00 PM - 5:05 PM ET

Introductions
Speaker: Yu, Jennifer, MD, PhD - Cleveland Clinic, Cleveland, OH
5:00 PM - 5:05 PM ET

Introductions
Speaker: Patel, Sagar, MD - Emory University, Atlanta, GA
5:00 PM - 5:05 PM ET

Introductions
Speaker: Jegadeesh, Naresh, MD - Cook Radiation Oncology, Chicago, Il
5:05 PM - 5:10 PM ET

1066 - Rb1-S780 Phosphorylation as a Potential Biomarker for Grade 1.5 Meningiomas and Adjuvant Radiotherapy Decision Making
Speaker: Guzel, Caglar, MD - Gazi University, Ankara
5:05 PM - 5:10 PM ET

1078 - Bone Marrow-Sparing Extended-Field Chemoradiation with Dose-Dense Neoadjuvant Chemotherapy for FIGO 2018 Stage IIIC2 Cervical Cancer: Early Outcomes of a Prospective Phase II Study
Speaker: Saini, Surendra Kumar, MD - ALL INDIA INSTITUTE OF MEDICAL SCIENCES,NEW DELHI,INDIA, NEW DELHI
5:05 PM - 5:10 PM ET

1091 - Phase III Trial to Compare Weekly and Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemoradiotherapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Yang, Dan, MD - Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, P.R. China, Beijing